221 related articles for article (PubMed ID: 38805522)
1. The interplay of Pseudomonas aeruginosa and Staphylococcus aureus in dual-species biofilms impacts development, antibiotic resistance and virulence of biofilms in in vitro wound infection models.
Vestweber PK; Wächter J; Planz V; Jung N; Windbergs M
PLoS One; 2024; 19(5):e0304491. PubMed ID: 38805522
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial effects of antibiotics and enzymes against dual-species Staphylococcus aureus and Pseudomonas aeruginosa biofilms in the wound-like medium.
Fanaei Pirlar R; Emaneini M; Beigverdi R; Banar M; B van Leeuwen W; Jabalameli F
PLoS One; 2020; 15(6):e0235093. PubMed ID: 32584878
[TBL] [Abstract][Full Text] [Related]
3. D-amino acids enhance the activity of antimicrobials against biofilms of clinical wound isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
Sanchez CJ; Akers KS; Romano DR; Woodbury RL; Hardy SK; Murray CK; Wenke JC
Antimicrob Agents Chemother; 2014 Aug; 58(8):4353-61. PubMed ID: 24841260
[TBL] [Abstract][Full Text] [Related]
4. Characterization of virulence factors, antimicrobial resistance patterns and biofilm formation of Pseudomonas aeruginosa and Staphylococcus spp. strains isolated from corneal infection.
Heidari H; Hadadi M; Sedigh Ebrahim-Saraie H; Mirzaei A; Taji A; Hosseini SR; Motamedifar M
J Fr Ophtalmol; 2018 Nov; 41(9):823-829. PubMed ID: 30292385
[TBL] [Abstract][Full Text] [Related]
5. Tolerant Small-colony Variants Form Prior to Resistance Within a Staphylococcus aureus Biofilm Based on Antibiotic Selective Pressure.
Manasherob R; Mooney JA; Lowenberg DW; Bollyky PL; Amanatullah DF
Clin Orthop Relat Res; 2021 Jul; 479(7):1471-1481. PubMed ID: 33835090
[TBL] [Abstract][Full Text] [Related]
6. The effect of Staphylococcus aureus on the antibiotic resistance and pathogenicity of Pseudomonas aeruginosa based on crc gene as a metabolism regulator: An in vitro wound model study.
Dehbashi S; Pourmand MR; Alikhani MY; Asl SS; Arabestani MR
Infect Genet Evol; 2020 Nov; 85():104509. PubMed ID: 32835876
[TBL] [Abstract][Full Text] [Related]
7. Next science wound gel technology, a novel agent that inhibits biofilm development by gram-positive and gram-negative wound pathogens.
Miller KG; Tran PL; Haley CL; Kruzek C; Colmer-Hamood JA; Myntti M; Hamood AN
Antimicrob Agents Chemother; 2014 Jun; 58(6):3060-72. PubMed ID: 24637684
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers.
Weldrick PJ; Hardman MJ; Paunov VN
ACS Appl Mater Interfaces; 2019 Nov; 11(47):43902-43919. PubMed ID: 31718141
[TBL] [Abstract][Full Text] [Related]
9.
Magalhães AP; Jorge P; Pereira MO
Crit Rev Microbiol; 2019; 45(5-6):712-728. PubMed ID: 31835971
[TBL] [Abstract][Full Text] [Related]
10. Activity of Norspermidine on Bacterial Biofilms of Multidrug-Resistant Clinical Isolates Associated with Persistent Extremity Wound Infections.
Cardile AP; Woodbury RL; Sanchez CJ; Becerra SC; Garcia RA; Mende K; Wenke JC; Akers KS
Adv Exp Med Biol; 2017; 973():53-70. PubMed ID: 27864804
[TBL] [Abstract][Full Text] [Related]
11. A novel in vitro flat-bed perfusion biofilm model for determining the potential antimicrobial efficacy of topical wound treatments.
Thorn RM; Greenman J
J Appl Microbiol; 2009 Dec; 107(6):2070-9. PubMed ID: 19548886
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies.
Farzi N; Oloomi M; Bahramali G; Siadat SD; Bouzari S
Probiotics Antimicrob Proteins; 2024 Jun; 16(3):796-814. PubMed ID: 37148452
[TBL] [Abstract][Full Text] [Related]
13. Activity of a nitric oxide-generating wound treatment system against wound pathogen biofilms.
Waite RD; Stewart JE; Stephen AS; Allaker RP
Int J Antimicrob Agents; 2018 Sep; 52(3):338-343. PubMed ID: 29665443
[TBL] [Abstract][Full Text] [Related]
14. Anthranilate Acts as a Signal to Modulate Biofilm Formation, Virulence, and Antibiotic Tolerance of Pseudomonas aeruginosa and Surrounding Bacteria.
Hwang HJ; Li XH; Kim SK; Lee JH
Microbiol Spectr; 2022 Feb; 10(1):e0146321. PubMed ID: 35019684
[TBL] [Abstract][Full Text] [Related]
15. A Pseudomonas aeruginosa Antimicrobial Affects the Biogeography but Not Fitness of Staphylococcus aureus during Coculture.
Barraza JP; Whiteley M
mBio; 2021 Mar; 12(2):. PubMed ID: 33785630
[No Abstract] [Full Text] [Related]
16.
Orazi G; O'Toole GA
mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
[TBL] [Abstract][Full Text] [Related]
17. The salicylidene acylhydrazide INP0341 attenuates Pseudomonas aeruginosa virulence in vitro and in vivo.
Uusitalo P; Hägglund U; Rhöös E; Scherman Norberg H; Elofsson M; Sundin C
J Antibiot (Tokyo); 2017 Aug; 70(9):937-943. PubMed ID: 28588224
[TBL] [Abstract][Full Text] [Related]
18. Antibiotics Enhance Prevention and Eradication Efficacy of Cathodic-Voltage-Controlled Electrical Stimulation against Titanium-Associated Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Biofilms.
Canty MK; Hansen LA; Tobias M; Spencer S; Henry T; Luke-Marshall NR; Campagnari AA; Ehrensberger MT
mSphere; 2019 May; 4(3):. PubMed ID: 31043516
[TBL] [Abstract][Full Text] [Related]
19. Controlling methicillin resistant Staphyloccocus aureus and Pseudomonas aeruginosa wound infections with a novel biomaterial.
Martineau L; Davis SC; Peng HT; Hung A
J Invest Surg; 2007; 20(4):217-27. PubMed ID: 17710602
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo anti-biofilm activity of pyran derivative against Staphylococcus aureus and Pseudomonas aeruginosa.
Su S; Yin P; Li J; Chen G; Wang Y; Qu D; Li Z; Xue X; Luo X; Li M
J Infect Public Health; 2020 May; 13(5):791-799. PubMed ID: 31813834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
